For Investors

InvesCare for Life Sciences Investors

Invescare provides solutions to key problems investors in life science technologies face regularly.

1. Do you find life sciences and biotechnology products and services investment opportunities too complex to analyse?
2. Have you invested in a product that fails because the science does not work?
3. Have you invested in a project that took longer than expected to get to market?
4. Have you invested in a project because you liked the academics and scientists without understanding the science?
5. Have you found exiting a business is taking longer than you thought because the product development and commercialisation is taking longer than expected?
6. Have you found estimating a fair valuation for a technology difficult because you cannot assess if the technology will work even though there may be a great market opportunity?
7. Are you looking to invest in new technologies in areas you do not have the relevant expertise in-house?

If your answer to any of the above questions is YES, then we are the people for you. Note that “half of published research cannot be replicated ¹ ²”, and other analyses have shown that there could be little or no scrutiny at many journals ³.

We will perform a comprehensive assessment of the technology and report to you with answers on the following questions:

• Are the inventors/scientists capable of delivering on the product based on their scientific knowledge/background and the current state of the art of supporting scientific tools required for delivery?
• Will the technology work as specified?
• Is the development time realistic?
• Are the development costs realistic based on the technical challenges involved?

The small investment you make by obtaining advice, which is provided by InvesCare’s business-savvy scientific experts will provide information to enable you to realistically assess technical risk and make an informed decision on how much to invest including valuation of the investment opportunity.

InvesCare will analyse the ability of the inventor/scientist to deliver based on their level of expertise in the scientific area, experience and track record. InvesCare experts will also analyse the timescales for product development and commercialization to determine if they are realistic based on the scientific challenges identified during the technology assessment.

The technology assessment report prepared by InvesCare will enable the investor to establish a fair valuation for the business proposition and to design a framework for investment tranche payments if they decide to proceed with the opportunity.

---

¹ The Economist, Oct 19th 2013, “Problems with scientific research. How science goes wrong.”
² The Economist, Oct 19th 2013, “Unreliable research. Trouble at the lab.”
³ Science 4 October 2013: Vol. 342 no. 6154 pp. 60-65 “Who’s Afraid of Peer Review?” by John Bohannon / The Economist, Oct 5th 2013, “Science’s Sokal moment. It seems dangerously easy to get scientific nonsense published.”